Mylan to sell up to $363 million stake in India's Biocon, term sheet shows
VTRS•Mylan plans Biocon share sale
SINGAPORE, July 13 (Reuters) - Mylan Inc plans to sell up to 92 million shares in Indian drugmaker Biocon Ltd BION.NS, worth up to 34.81 billion Indian rupees ($363 million), according to a term sheet seen by Reuters.
($1 = 95.6200 Indian rupees)




